rs79746977

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_024753.5(TTC21B):​c.2500C>T​(p.Gln834Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 1,613,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 0 hom. )

Consequence

TTC21B
NM_024753.5 stop_gained

Scores

5
1
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 8.09
Variant links:
Genes affected
TTC21B (HGNC:25660): (tetratricopeptide repeat domain 21B) This gene encodes a member of TTC21 family, containing several tetratricopeptide repeat (TPR) domains. This protein is localized to the cilium axoneme, and may play a role in retrograde intraflagellar transport in cilia. Mutations in this gene are associated with various ciliopathies, nephronophthisis 12, and asphyxiating thoracic dystrophy 4. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-165907746-G-A is Pathogenic according to our data. Variant chr2-165907746-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 446649.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-165907746-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TTC21BNM_024753.5 linkuse as main transcriptc.2500C>T p.Gln834Ter stop_gained 19/29 ENST00000243344.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TTC21BENST00000243344.8 linkuse as main transcriptc.2500C>T p.Gln834Ter stop_gained 19/291 NM_024753.5 P1Q7Z4L5-1

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152104
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000638
AC:
16
AN:
250924
Hom.:
0
AF XY:
0.0000664
AC XY:
9
AN XY:
135642
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000172
AC:
251
AN:
1460860
Hom.:
0
Cov.:
30
AF XY:
0.000182
AC XY:
132
AN XY:
726776
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000220
Gnomad4 OTH exome
AF:
0.0000994
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152222
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000206
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000145
Hom.:
0
Bravo
AF:
0.0000718
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Short-rib thoracic dysplasia 6 with or without polydactyly Pathogenic:2
Likely pathogenic, no assertion criteria providedresearchUniversity of Washington Center for Mendelian Genomics, University of Washington-- -
Pathogenic, no assertion criteria providedresearchDan Cohn Lab, University Of California Los AngelesJun 01, 2017- -
Jeune thoracic dystrophy;C0687120:Nephronophthisis Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 30, 2023This sequence change creates a premature translational stop signal (p.Gln834*) in the TTC21B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TTC21B are known to be pathogenic (PMID: 18327258, 21068128, 21258341, 23559409, 24876116, 25492405, 27491411, 29068549). This variant is present in population databases (rs79746977, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with short-rib polydactyly syndromes (PMID: 29068549). ClinVar contains an entry for this variant (Variation ID: 446649). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingGenetic Services Laboratory, University of ChicagoAug 16, 2022DNA sequence analysis of the TTC21B gene demonstrated a sequence change, c.2500C>T, which results in the creation of a premature stop codon at amino acid position 834, p.Gln834*. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated TTC21B protein with potentially abnormal function. This sequence change has been described in the gnomAD database with a frequency of 0.006% in the overall population (rs115348383). This sequence change has previously been described in the compound heterozygous state in an individual with short-rib polydactyly syndrome type II (PMID: 29068549).This collective evidence indicates that this sequence change is likely pathogenic; however, functional studies have not been performed to determine this conclusively. This sequence change in the heterozygous state is not sufficient to cause autosomal recessive TTC21B-related disorders. However, the contribution of a single pathogenic sequence change in TTC21B remains unclear at this time. -
TTC21B-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesNov 08, 2023The TTC21B c.2500C>T variant is predicted to result in premature protein termination (p.Gln834*). This variant was reported in compound heterozygous state in an individual with short rib-polydactyly syndrome (Patient R08-045A in Table S2, Zhang et al. 2018. PubMed ID: 29068549) and in two siblings with early onset hypertension and tubuloglomerular kidney disease (Olinger et al. 2022. PubMed ID: 35289079). This variant is reported in 0.013% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-166764256-G-A). Nonsense variants in TTC21B are expected to be pathogenic. This variant is interpreted as likely pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.47
D
BayesDel_noAF
Pathogenic
0.63
CADD
Pathogenic
43
DANN
Uncertain
1.0
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.98
FATHMM_MKL
Pathogenic
0.99
D
MutationTaster
Benign
1.0
A
Vest4
0.28
GERP RS
5.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.36
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.36
Position offset: 38

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs79746977; hg19: chr2-166764256; API